Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adult medulloblastoma: multiagent chemotherapy.

H S Greenberg1, M C Chamberlain, M J Glantz

  • 1Department of Neurology, University of Michigan, Ann Arbor 48109, USA.

Neuro-Oncology
|April 18, 2001
PubMed
Summary

This study reviewed 17 adult medulloblastoma patients treated with craniospinal radiation and chemotherapy. The Pediatric Oncology Group (POG) protocol showed less toxicity and similar survival compared to the Packer protocol.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Systemic therapy for recurrent meningioma.

Expert review of neurotherapeutics·2016
Same author

Treatment of newly diagnosed malignant glioma in the elderly people: new trials that impact therapy.

International journal of clinical practice·2013
Same author

A retrospective case series of 103 consecutive patients with leptomeningeal metastasis and breast cancer.

Journal of neuro-oncology·2013
Same author

Treatment and prevention of secondary CNS lymphoma.

Seminars in neurology·2010
Same author

Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report.

Annals of oncology : official journal of the European Society for Medical Oncology·2007
Same author

Diagnosis and outcome measures in trials for neoplastic meningitis: a review of the literature and clinical experience.

Neurosurgical focus·2006

Area of Science:

  • Neuro-oncology
  • Radiation oncology
  • Medical oncology

Background:

  • Medulloblastoma is a primary brain tumor predominantly affecting children but also occurring in adults.
  • Treatment typically involves surgery, craniospinal radiation (CSRT), and adjuvant chemotherapy.
  • Optimal chemotherapy regimens for adult medulloblastoma following CSRT remain under investigation.

Purpose of the Study:

  • To review outcomes of adult medulloblastoma patients treated with CSRT and one of two chemotherapy protocols.
  • To compare progression-free survival (PFS), overall survival (OS), and toxicity between the Packer and Pediatric Oncology Group (POG) protocols.
  • To assess the efficacy and safety of adjuvant chemotherapy in adult medulloblastoma patients.

Main Methods:

  • Retrospective review of 17 adult medulloblastoma patients treated at three institutions.

Related Experiment Videos

  • Patients received surgery, CSRT with local boost, and either the Packer or POG chemotherapy protocol.
  • Outcomes assessed included PFS, OS, and treatment-related toxicities using Kaplan-Meier analysis.

    • Main Results:

    • Eight of 17 patients relapsed, primarily at the primary site; median PFS was 48 months.
    • Median OS for all patients was 56 months; POG protocol showed a trend towards better survival (57 vs. 36 months).
    • The POG protocol demonstrated significantly less nonhematologic toxicity compared to the Packer protocol.

    Conclusions:

    • The POG chemotherapy protocol appears to offer comparable survival with reduced toxicity versus the Packer protocol in adult medulloblastoma.
    • Small sample size limits statistical significance in survival comparisons between the two protocols.
    • Larger randomized trials are needed to definitively establish the role of adjuvant chemotherapy in adult medulloblastoma treatment.